- Home
- IVDA vs RNAZ Comparison
IVDA vs RNAZ Comparison
Compare IVDA & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- RNAZ
- Stock Information
- Founded
- IVDA 2003
- RNAZ 2016
- Country
- IVDA United States
- RNAZ United States
- Employees
- IVDA N/A
- RNAZ N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- RNAZ Health Care
- Exchange
- IVDA Nasdaq
- RNAZ Nasdaq
- Market Cap
- IVDA 6.7M
- RNAZ 6.1M
- IPO Year
- IVDA N/A
- RNAZ 2021
- Fundamental
- Price
- IVDA $1.96
- RNAZ $7.97
- Analyst Decision
- IVDA
- RNAZ Strong Buy
- Analyst Count
- IVDA 0
- RNAZ 1
- Target Price
- IVDA N/A
- RNAZ $280.00
- AVG Volume (30 Days)
- IVDA 161.4K
- RNAZ 32.8K
- Earning Date
- IVDA 08-13-2025
- RNAZ 08-13-2025
- Dividend Yield
- IVDA N/A
- RNAZ N/A
- EPS Growth
- IVDA N/A
- RNAZ N/A
- EPS
- IVDA N/A
- RNAZ N/A
- Revenue
- IVDA $7,148,449.00
- RNAZ N/A
- Revenue This Year
- IVDA $340.48
- RNAZ N/A
- Revenue Next Year
- IVDA N/A
- RNAZ N/A
- P/E Ratio
- IVDA N/A
- RNAZ N/A
- Revenue Growth
- IVDA 54.15
- RNAZ N/A
- 52 Week Low
- IVDA $1.27
- RNAZ $6.15
- 52 Week High
- IVDA $8.05
- RNAZ $970.20
- Technical
- Relative Strength Index (RSI)
- IVDA 41.16
- RNAZ 47.04
- Support Level
- IVDA $1.71
- RNAZ $7.32
- Resistance Level
- IVDA $2.09
- RNAZ $8.48
- Average True Range (ATR)
- IVDA 0.17
- RNAZ 0.58
- MACD
- IVDA -0.02
- RNAZ 0.41
- Stochastic Oscillator
- IVDA 12.05
- RNAZ 70.77
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.